bpc-157 risks human studies BPC-157: Experimental Peptide Creates Risk for Athletes FDA's Review Of Peptides Signals

Payandeh Z, Khalili S, Somi MH, Mard-Soltani M, Baghbanzadeh A, Hajiasgharzadeh K, et al

Prompt parenteral B12 treatment should be initiated without delay in such cases, in line with BSH guidance, to minimise the risk of permanent neurological damage

Hormones: Its really common to hear about psoriasis showing up at the times hormones are changing: in puberty, pregnancy or during the menopause

Reported benefits (per available research): FDA-approved, clinical-trial-supported reduction of excess visceral abdominal fat in HIV-associated lipodystrophy, the only indication with robust human RCT evidence behind it Studied in a randomized, placebo-controlled trial for possible support of executive function and cognitive performance in healthy older adults and adults with mild cognitive impairment (Baker et al., 2012) Proposed, but far less rigorously studied in healthy or bodybuilding populations, to support lean body mass and body composition changes through GH/IGF-1 axis stimulation